Schering-Plough Corporation

Jul 02, 08
	NEW STORY
02:00 ET	Schering-Plough Announces Closing of Planned Divestiture of Selected Animal Health Products
Jun 27, 08
08:00 ET	Schering-Plough and Merck Announce Withdrawal of Loratadine/Montelukast NDA and Termination of Respiratory Joint Venture
Jun 26, 08
07:30 ET	Survey Shows Knee and Lower Back Pain Contribute to Insomnia, Weight Gain, Money Loss and More
Jun 24, 08
13:23 ET	Schering-Plough Declares Quarterly Dividends on Common Shares and 2007 Mandatory Convertible Preferred Stock
Jun 17, 08
10:37 ET	Schering-Plough Schedules Conference Call and Webcast for 2008 Second Quarter Earnings
Jun 11, 08
16:00 ET	Schering-Plough Announces Fruit of the Earth to Change Sun Care Packaging After Court Hearing
Jun 03, 08
08:30 ET	ViroDefense Inc Announces Selection of Poliovirus Antiviral Preclinical Candidate
Jun 02, 08
08:19 ET	Schering-Plough's Sugammadex Provides Fast Reversal of Effects of Muscle Relaxants Used in General Anesthesia
06:51 ET	European Union's CHMP Issues Positive Opinion on Sugammadex
May 30, 08
15:31 ET	About 60 Clinical Studies Regarding Schering-Plough's Oncology Compounds Will be Presented at ASCO
May 27, 08
12:06 ET	Schering-Plough Appoints Janet M. Barth Vice President, Investor Relations
May 21, 08
12:31 ET	Schering-Plough Elects Tessa Hilado Vice President and Treasurer
11:54 ET	Hurricane Season Begins June 1 - Pets Need Protection, Too!
08:30 ET	Schering-Plough To Initiate Phase III Studies With HCV Protease Inhibitor Boceprevir in Previously Untreated Hepatitis C Patients and Those Who Failed Prior Treatment
May 19, 08
13:46 ET	Prof. Dr. George Gettinby Honored With Dieter Lutticken Award
May 15, 08
16:25 ET	Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting
May 09, 08
13:37 ET	Schering-Plough Schedules Webcast for Annual Meeting of Shareholders
May 08, 08
11:00 ET	Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting
May 06, 08
08:30 ET	Actress and Mom Lori Loughlin Raises Awareness About the Potential Dangers of Drowsy Driving During Allergy Season
Apr 30, 08
14:29 ET	Intervet/Schering-Plough Animal Health Outlines Strength of the Combination
Apr 26, 08
12:01 ET	Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL)
12:00 ET	Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL
Apr 25, 08
20:59 ET	Schering-Plough/MERCK Pharmaceuticals Receives Not-Approvable Letter from FDA for Loratadine/Montelukast
Apr 24, 08
12:21 ET	Schering-Plough CEO Buys $2 Million in Common Shares
Apr 23, 08
16:30 ET	Schering-Plough Announces Planned Divestiture of Select Animal Health Products in Europe
06:45 ET	Schering-Plough Reports Financial Results for First Quarter of 2008
Apr 17, 08
08:30 ET	Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting
Apr 16, 08
13:48 ET	Schering-Plough Announces Imperfect Contraceptive Use Impacts Women's Emotional Well-Being
Apr 15, 08
13:10 ET	Video: Julianne Hough From Dancing With the Stars(TM) Has a New Partner: DR. SCHOLL'S(R) FOR HER
08:30 ET	Schering-Plough Initiates Phase II Study With Vicriviroc in Treatment-Naive HIV-Infected Patients
Apr 14, 08
15:17 ET	Schering-Plough Schedules Conference Call and Webcast for 2008 First Quarter Earnings
Apr 11, 08
14:44 ET	Schering-Plough Announces Expanded Stock Retention Guidelines for Senior Management
Apr 02, 08
17:19 ET	Schering-Plough Launches Productivity Transformation Program To Confront New Challenges
Mar 27, 08
08:30 ET	Pegintron(TM) Plus Weight-Based Rebetol(R) Resulted in Higher SVR Than Flat Dosing; Low Relapse Rates in Patients With Chronic Hepatitis C
Mar 20, 08
07:00 ET	New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly
Mar 18, 08
13:00 ET	The Makers of COPPERTONE Launch SPF 70+ the Highest SPF Continuous Spray Sunscreen Available
08:00 ET	Video: 'Clear to Drive' Campaign Educates Motorists on How to Prevent Drowsy Driving
Mar 11, 08
17:09 ET	FDA Advisory Committee Unanimously Recommends U.S. Approval of Sugammadex, the First and Only Selective Relaxant Binding Agent
08:00 ET	Schering-Plough Announces Filing of U.S. Application for OTC ZEGERID(R)
Mar 10, 08
17:08 ET	Schering-Plough to Webcast Presentation by CEO Fred Hassan at Lehman Brothers Eleventh Annual Global Healthcare Conference
Feb 29, 08
14:20 ET	Schering-Plough Promotes Ian Mcinnes to President of Global Supply Chain
11:40 ET	Schering-Plough Declares Quarterly Dividends on Common Shares and 2007 Mandatory Convertible Preferred Stock
Feb 12, 08
06:50 ET	Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year
Feb 11, 08
08:00 ET	Schering-Plough and OraSure Technologies Sign International Collaboration for Rapid Point-of-Care Oral Hepatitis C Test
Feb 08, 08
15:10 ET	Schering-Plough Announces Organizational Changes at Schering-Plough Research Institute
Feb 06, 08
18:00 ET	Vicriviroc Demonstrates Potent and Sustained Viral Suppression Through 48 Weeks of Therapy in Treatment-Experienced HIV-Infected Patients
Feb 04, 08
08:00 ET	FDA Approves ASMANEX (R) TWISTHALER(R) (Mometasone Furoate Inhalation Powder) for the Once Daily Maintenance Treatment of Asthma in Children Ages 4-11
Feb 01, 08
08:30 ET	Video and Photo: CLARITIN(R) Signs First-Time Sponsorship Agreement With Allergy Sufferer and NASCAR Sprint Cup Driver Carl Edwards
Jan 31, 08
14:00 ET	New IDSA Clinical Practice Guidelines Recommend NOXAFIL(R) (Posaconazole) for Antifungal Prophylaxis in Certain High-Risk Patients
08:00 ET	FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma
Jan 22, 08
08:33 ET	FDA Approves Labeling Change for Non-Drowsy CLARITIN(R)
Jan 18, 08
10:19 ET	Schering-Plough CEO to Buy $2 Million in Common Shares
Jan 17, 08
11:03 ET	Schering-Plough Announces Sugammadex New Drug Application Filed in Japan
Jan 14, 08
09:16 ET	Schering-Plough Reports Top-Line Results of the IDEAL Study
Jan 03, 08
12:00 ET	Schering-Plough Board Elects Dr. Craig B. Thompson as a Director
Jan 02, 08
16:55 ET	Schering-Plough Announces New Drug Application for Sugammadex Assigned Priority Review Status by U.S. FDA
Dec 27, 07
14:07 ET	Schering-Plough to Webcast Presentation at Morgan Stanley Pharmaceutical CEOs Unplugged Conference
11:52 ET	Schering-Plough Schedules Conference Call and Webcast for 2007 Fourth Quarter, Full-Year Financial Result
Dec 21, 07
14:40 ET	Centocor, Schering-Plough Revise Agreement Covering REMICADE, Golimumab
Dec 19, 07
14:59 ET	MiraLAX(R) #1 in Non-Fiber OTC Laxative Category
Dec 17, 07
14:22 ET	New Study Results Show Asenapine More Effective Than Placebo in the Treatment of Acute Schizophrenia
Dec 14, 07
11:03 ET	Schering-Plough Declares Quarterly Dividends on Common Shares and 2007 Mandatory Convertible Preferred Stock
Dec 10, 07
10:30 ET	New Study Shows LEVITRA Successfully Treats Erectile Dysfunction (ED) in Men with Dyslipidemia, Including High Cholesterol
Dec 05, 07
16:58 ET	Schering-Plough Wins Three of Scrip's Top Pharma Industry Awards
Nov 26, 07
00:01 ET	Schering-Plough Announces Asenapine NDA Accepted for Filing by the U.S. FDA
Nov 19, 07
10:00 ET	Schering-Plough Completes Acquisition of Organon BioSciences
Nov 16, 07
09:18 ET	Schering-Plough Receives Clearance From U.S. Federal Trade Commission for Planned Acquisition of Organon Biosciences N.V.
Nov 15, 07
02:00 ET	PEGINTRON(TM) and REBETOL(R) Approved in European Union for Retreating Hepatitis C Patients Who Failed Previous Pegylated or Non-Pegylated Interferon Therapy
Nov 09, 07
16:20 ET	Schering-Plough to Webcast CFO Robert J. Bertolini's Presentation at 2007 Credit Suisse Health Care Conference
Nov 07, 07
10:00 ET	SCH 530348 (TRA), a Novel Investigational Antiplatelet Agent, Shown to Inhibit Platelet Aggregation in PCI Patients
Nov 05, 07
16:53 ET	Addition of INTEGRILIN(R) (Eptifibatide) to Bivalirudin Plus Standard of Care Inhibits Platelet Aggregation in Patients Undergoing Elective Coronary Stenting
16:05 ET	Schering-Plough Reports U.S. District Court for District of Massachusetts Finds No Liability for Subsidiary in AWP Case
Nov 02, 07
16:23 ET	Schering-Plough CEO Calls for Four-Pronged Approach to Improving Current Health Care Environment
Oct 30, 07
10:00 ET	Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting
08:00 ET	Long-Term Data from a Landmark Phase III Trial Show Survival Benefit at Three- and Four-Years in Patients with Glioblastoma multiforme
Oct 29, 07
08:37 ET	Bringing Pets Home
Oct 25, 07
08:40 ET	Schering-Plough Announces New Claritin(R) Dry Syrup Formulation Approved in Japan for Children Ages 3 to 7
Oct 22, 07
06:54 ET	Schering-Plough Reports Financial Results for Third Quarter of 2007
06:00 ET	Schering-Plough Reports Two Phase II Studies of Thrombin Receptor Antagonist (TRA) Build on Findings from Previous Phase II Study
Oct 18, 07
08:30 ET	Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response
Oct 11, 07
12:29 ET	Schering-Plough Receives Approval from European Commission for Planned Acquisition of Organon BioSciences N.V.
Sep 26, 07
17:23 ET	Schering-Plough Announces Pricing of Euro-Denominated Senior Notes Offering
Sep 24, 07
08:30 ET	European Union's CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
Sep 21, 07
17:03 ET	Schering-Plough Schedules Conference Call and Webcast for 2007 Third Quarter Earnings
Sep 19, 07
08:53 ET	Schering-Plough Declares Quarterly Dividends on Common Shares and 2007 Mandatory Convertible Preferred Stock
Sep 18, 07
15:50 ET	Schering-Plough to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
Sep 17, 07
08:30 ET	Schering-Plough Initiates Phase III Studies with Vicriviroc in Treatment- Experienced HIV Patients
Sep 13, 07
09:21 ET	Schering-Plough Announces Conversion of 2004 Mandatory Convertible Preferred Stock
Sep 12, 07
18:00 ET	Schering-Plough Announces Pricing of Senior Notes Offering
Aug 28, 07
08:00 ET	Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
Aug 09, 07
20:58 ET	Schering-Plough Corporation Prices Public Offering of Common Shares and 6.00% Mandatory Convertible Preferred Stock
Aug 02, 07
13:33 ET	Schering-Plough Announces Dissolution of Consent Decree
06:30 ET	Schering-Plough Corporation Announces Commencement of Public Offering of Common Shares and Mandatory Convertible Preferred Stock
Jul 24, 07
08:30 ET	Vicriviroc Demonstrates Potent Viral Suppression Through 48 Weeks of Therapy in ACTG Phase II Study in Treatment-Experienced HIV Patients
Jul 23, 07
06:51 ET	Schering-Plough Reports Financial Results for Second Quarter of 2007
Jul 19, 07
08:30 ET	Schering-Plough Announces Licensing of Acadesine, an Investigational Agent Being Studied for Prevention of Complications From Cardiac Surgery
Jul 02, 07
14:55 ET	Actress Vanessa Williams and HomeAgain(R) Encourage Pet Owners to Take Important Summer Safety Precautions for Pets
Jun 26, 07
12:49 ET	Schering-Plough Declares Quarterly Dividends on Common Shares and Mandatory Convertible Preferred Stock
Jun 25, 07
02:00 ET	PEGINTRON(TM) and REBETOL(R) Combination Therapy Approved in European Union for Treating Hepatitis C in Patients Coinfected With HIV
Jun 21, 07
16:04 ET	Schering-Plough Reports on Favorable Rulings in AWP Case By U.S. District Court for District of Massachusetts
Jun 18, 07
17:28 ET	Schering-Plough Schedules Conference Call and Webcast For 2007 Second Quarter Earnings
Jun 15, 07
08:00 ET	REMICADE(R) Two Year Data in Ankylosing Spondylitis Show Improvement in Spinal Mobility and Spinal Inflammation
Jun 12, 07
09:48 ET	Schering-Plough To Webcast CFO Robert J. Bertolini's Presentation at Goldman Sachs 28th Annual Global Healthcare Conference
Jun 11, 07
07:03 ET	Kurve Technology and Schering-Plough Sign Expanded Technology Agreement
Jun 08, 07
08:00 ET	Schering-Plough and Bayer Healthcare Announce Availability of ZETIA in Japan, the First Cholesterol-Lowering Agent With a Novel Mechanism of Action Approved in Japan in 18 Years
Jun 07, 07
08:00 ET	Remicade(R) Receives EU Approval as First and Only Biologic Treatment for Pediatric Crohn's Disease
Jun 03, 07
10:30 ET	CAELYX(R) Delays Time to Disease Progression as Maintenance Therapy in Patients with Metastatic Breast Cancer
Jun 02, 07
08:30 ET	Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
May 30, 07
09:57 ET	Novacea and Schering-Plough Enter into Worldwide Development and Commercialization Agreement for Asentar, a Novel Treatment for Prostate Cancer
May 18, 07
11:15 ET	Schering-Plough Announces Hepatitis C Data Presentations at Digestive Disease Week (DDW) 2007 Annual Meeting
May 08, 07
07:57 ET	Schering-Plough Schedules Webcast for Annual Meeting of Shareholders
May 04, 07
09:14 ET	Schering-Plough Receives Request for Additional Information From Federal Trade Commission in Connection With Planned Organon Biosciences N.V. Transaction
Apr 30, 07
02:00 ET	European Union's CHMP Issues Positive Opinion on PEGINTRON(Tm) and REBETOL(R) Combination Therapy for Hepatitis C in Patients Coinfected With HIV
Apr 19, 07
06:25 ET	Schering-Plough Reports Financial Results for First Quarter of 2007
Apr 18, 07
18:02 ET	Schering-Plough Announces ZETIA Approved in Japan for Treatment of High Cholesterol
17:36 ET	Schering-Plough Announces Initiation of Two Phase III Clinical Trials for Novel Selective Antiplatelet Therapy (TRA-SCH 530348)
Apr 11, 07
02:00 ET	Schering-Plough Addresses Major Milestones and Challenges in Treatment of Patients With Chronic Hepatitis C
Apr 09, 07
08:08 ET	Schering-Plough Schedules Conference Call and Webcast for 2007 First Quarter Earnings
Apr 05, 07
08:00 ET	PEGINTRON(TM) Approved in China for Treating Chronic Hepatitis B
Mar 28, 07
07:54 ET	MiraLAX(R), Number One Doctor-Prescribed Laxative, Now Available Over The Counter
Mar 26, 07
08:30 ET	Schering-Plough and Merck to Develop Another New Cholesterol Lowering Medicine
02:30 ET	European Union CHMP Recommends Approval of First and Only Biologic Treatment for Pediatric Crohn's Disease: REMICADE(R)
Mar 24, 07
13:00 ET	Schering-Plough's Novel Oral Thrombin Receptor Antagonist Meets Primary Endpoint in Phase II Trial
Mar 20, 07
15:30 ET	New Cancer Practice Guidelines Recommend NOXAFIL(R) (Posaconazole) for Antifungal Prophylaxis in Certain High-Risk Patients
Mar 19, 07
10:27 ET	Schering-Plough to Webcast CEO Fred Hassan's Presentation at Lehman Brothers Tenth Annual Global Healthcare Conference
Mar 16, 07
08:00 ET	Media Advisory: ACC Updated Schedule
Mar 12, 07
09:00 ET	Schering-Plough Announces Presentation of Phase II Trial Results for Novel Oral Thrombin Receptor Antagonist at the 2007 Annual Meeting of The American College of Cardiology/i2 Summit
08:32 ET	Schering-Plough Announces Presentation of Phase II Trial Results for Novel Oral Thrombin Receptor Antagonist at the 2007 Annual Meeting of The American College of Cardiology/i2 Summit
03:01 ET	Schering-Plough to Acquire Organon BioSciences
Feb 28, 07
16:44 ET	Schering-Plough Announces Executive Changes in Research
08:00 ET	NASONEX(R) Earns the Arthritis Foundation Ease-of-Use Commendation
Feb 27, 07
09:57 ET	Schering-Plough Declares Quarterly Dividends on Common Shares and Mandatory Convertible Preferred Stock
Feb 21, 07
11:09 ET	Schering-Plough to Webcast Presentation at Bear Stearns Healthcare Conference
Feb 13, 07
16:44 ET	James R. Nelson Retires from Schering-Plough
Feb 05, 07
18:16 ET	Schering-Plough Announces Executive Management Team Changes
Feb 02, 07
10:43 ET	Schering-Plough Cites Today's Anacor Agreement as Latest in Series of Deals
Jan 31, 07
11:03 ET	Schering-Plough to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
08:00 ET	Schering-Plough Appoints Shaju Backer
Jan 29, 07
06:57 ET	Schering-Plough Reports Financial Results for 2006 Fourth Quarter, Full Year
Jan 26, 07
15:20 ET	Schering-Plough Corporation Mourns Death of Bruce R. Reid, Leader in Pharmaceutical Business
Jan 25, 07
02:00 ET	The New England Journal Of Medicine Publishes Two Landmark Studies Of NOXAFIL(R) (Posaconazole) in the Prevention of Invasive Fungal Infections
Jan 15, 07
07:52 ET	Schering-Plough Launches New National HomeAgain(TM) Proactive Pet Recovery Network
Jan 04, 07
08:00 ET	Schering-Plough and OraSure Technologies Sign Agreement for Development and Promotion of Rapid Point-Of-Care Oral Hepatitis C Test
Dec 22, 06
08:35 ET	Schering-Plough Schedules Conference Call, Webcast for 2006 Fourth Quarter and Full-Year Earnings
08:00 ET	Fulford (India) Limited Appoints K.G. Ananthakrishnan as Chief Operating Officer and President and Managing Director - Designate
Dec 19, 06
17:22 ET	Schering-Plough to Webcast Presentation at Morgan Stanley Pharmaceutical CEOs Unplugged Conference
Dec 15, 06
12:14 ET	Schering-Plough Declares Quarterly Dividends on Common Shares and Mandatory Convertible Preferred Stock
08:23 ET	Schering-Plough Announces Four Key Corporate Governance Actions
Dec 13, 06
16:30 ET	Schering-Plough Licenses Worldwide Rights to Pradefovir, Oral Hepatitis B Treatment In Development With Valeant Pharmaceuticals and Metabasis Therapeutics
Dec 05, 06
17:50 ET	Schering-Plough Enters Licensing Agreement to Market Prescription MiraLAX(R) Over-The-Counter
Nov 27, 06
08:00 ET	Schering-Plough Appoints Thierry Powis President Director, Indonesia
Nov 13, 06
11:59 ET	Schering-Plough to Webcast Presentation at 2006 Credit Suisse Health Care Conference
Nov 10, 06
17:21 ET	Schering-Plough CEO Calls on New Congress to 'Do What Is Right' for the Patient, Calls for 'Scorecards' to Rate Managed Care Performance
Nov 09, 06
02:00 ET	Noxafil(R) (Posaconazole) Oral Suspension Approved in European Union for Prevention of Invasive Fungal Infections
Nov 03, 06
07:00 ET	Newly-Published Data Showed LEVITRA(R) Treated Erectile Dysfunction Effectively at First Dose In Men With Certain Associated Cardiovascular Conditions
Nov 01, 06
11:57 ET	Schering-Plough Expanding Discovery Operations in Cambridge, Mass.
Oct 31, 06
08:00 ET	Schering-Plough Appoints Eduardo Cortes General Manager, Argentina
Oct 27, 06
08:30 ET	Results of PEG-INTRON(R) and REBETOL(R) Study in Retreating Hepatitis C Patients Who Failed Previous Combination Therapy Presented at AASLD
Oct 24, 06
08:30 ET	Schering-Plough Highlights Hepatitis C Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2006 Annual Meeting
Oct 23, 06
08:00 ET	Schering-Plough Announces FDA Approval of NOXAFIL(R) (Posaconazole) for Treatment of Oropharyngeal Candidiasis (OPC)
Oct 20, 06
07:01 ET	Schering-Plough Reports Financial Results for 2006 Third Quarter
Oct 12, 06
16:51 ET	Schering-Plough Chairman/CEO Fred Hassan Named New President of IFPMA
Oct 06, 06
02:00 ET	SUBOXONE(R) (Buprenorphine/Naloxone) Approved In European Union for Treatment of Opioid Dependence
Oct 03, 06
15:06 ET	Schering-Plough Schedules Conference Call and Webcast for Third Quarter 2006 Earnings
Sep 29, 06
13:30 ET	Efficacy of Once-Daily AVELOX(R) in Treating Complicated Intra-Abdominal Infections Highlighted in Two Clinical Data Presentations at ICAAC
Sep 22, 06
02:00 ET	European Union's CHMP Adopts Positive Opinion for NOXAFIL(R) (posaconazole) Oral Suspension for Prevention of Invasive Fungal Infections
Sep 19, 06
12:06 ET	Schering-Plough Declares Quarterly Dividends on Common Shares and Mandatory Convertible Preferred Stock
08:59 ET	Thomas P. Koestler, Ph.D., Elected Head of Schering-Plough R&D
Sep 18, 06
08:00 ET	Schering-Plough Announces FDA Approval of NOXAFIL(R) (Posaconazole) for Prevention of Invasive Fungal Infections
Sep 08, 06
09:21 ET	Schering-Plough to Webcast Presentation at Bear Stearns 19th Annual Healthcare Conference
Aug 29, 06
10:45 ET	Schering-Plough Reaches Agreement With U.S. Attorney's Office for District of Massachusetts and U.S. Department of Justice
Aug 25, 06
15:26 ET	New CHILDREN'S CLARITIN(R) Grape Chewables Provide Non-Jittery, Non-Drowsy, All Day Relief for Kids' Allergy Symptoms
Aug 17, 06
16:00 ET	Vicriviroc Demonstrates Potent and Sustained Viral Suppression in ACTG Phase II Clinical Study in Treatment-Experienced HIV Patients
15:36 ET	Schering-Plough Receives Clarification of Its Rights for Golimumab
Aug 14, 06
08:30 ET	Schering-Plough Appoints Trevor Juniper General Manager, Schering-Plough China
01:36 ET	Schering-Plough Announces Global Agreement With Novartis to Develop Once-Daily Combination Therapy for Asthma and COPD
Jul 31, 06
13:30 ET	Schering-Plough Corporation Mourns Death of Jonathan R. Spicehandler, M.D., Retired R&D Head
07:30 ET	TEMODAL(R) Approved by Japan's Ministry of Health, Labor and Welfare for Patients With Malignant Gliomas
Jul 28, 06
08:59 ET	European Union's CHMP Adopts Positive Opinion for SUBOXONE(R) (Buprenorphine/Naloxone) for Treatment of Opioid Dependence
Jul 25, 06
08:30 ET	Study Shows Once-Daily AVELOX(R) as Effective as Multi-Dose Combination Therapy in Treating Complicated Intra-Abdominal Infections
Jul 24, 06
06:45 ET	Schering-Plough Reports Financial Results for 2006 Second Quarter
Jul 17, 06
08:32 ET	Schering-Plough Appoints John M. Carroll Vice President, Global Internal Audits
Jul 12, 06
08:30 ET	Schering-Plough Announces Executive Changes in Schering-Plough Research Institute
Jun 30, 06
12:34 ET	Jonathan R. Spicehandler, M.D. Retires From Schering-Plough
Jun 27, 06
14:15 ET	Schering-Plough Declares Quarterly Dividends On Common Shares and Mandatory Convertible Preferred Stock
Jun 21, 06
08:30 ET	Schering-Plough to Expand Its Presence in Latin America, Restructure Commercial Operations in Brazil
Jun 19, 06
13:07 ET	New Study Showed VYTORIN(R) (ezetimibe/simvastatin) Significantly More Effective than Crestor(R) (rosuvastatin) at Lowering LDL 'Bad' Cholesterol at All Doses Compared
Jun 09, 06
16:52 ET	Schering-Plough Schedules Conference Call and Webcast for Second Quarter 2006 Earnings
11:03 ET	Schering-Plough to Webcast CFO Robert J. Bertolini's Presentation at Goldman Sachs 27th Annual Global Healthcare Conference
06:00 ET	Most U.S. Men Unaware of Link Between Erectile Dysfunction and Common Health Problems Such as High Blood Pressure
Jun 06, 06
08:30 ET	Schering-Plough to Adopt Global Model for Planning, Managing Clinical Trials
Jun 01, 06
08:30 ET	Schering-Plough Announces Changes to Manufacturing Operations
May 23, 06
08:30 ET	Schering-Plough Initiates PEG-INTRON 'PROTECT' Study in Liver Transplant Patients with Recurrent Hepatitis C
May 22, 06
08:21 ET	New DR. SCHOLL'S(R) DUAL ACTION FREEZE AWAY(TM) Brings Home Powerful Relief for Large, Stubborn Warts
May 19, 06
16:39 ET	Schering-Plough Announces Strategy and Action Plan on Social Issues
May 18, 06
08:30 ET	Schering-Plough Announces Hepatitis C Data Presentations at Digestive Disease Week (DDW) 2006 Annual Meeting
May 15, 06
08:33 ET	Schering-Plough Schedules Webcast for Annual Meeting of Shareholders
May 09, 06
14:19 ET	Goodbye to the Beach Battle: COPPERTONE KIDS(R) CONTINUOUS SPRAY SPF 50 Makes Sunscreen Application Easier for Parents
May 01, 06
15:53 ET	National Survey Reveals That Losing a Pet Can Be More Traumatic Than Losing a Job
Apr 28, 06
13:21 ET	Schering-Plough To Webcast Presentation At Deutsche Bank 31st Annual Health Care Conference
Apr 26, 06
02:00 ET	EU Label Change for INTRON(R) A (interferon Alfa-2b) Incorporates Long-Term Efficacy Data in Patients with Chronic Hepatitis C
Apr 20, 06
06:42 ET	Schering-Plough Reports Financial Results for First Quarter of 2006
02:00 ET	Schering-Plough Provides Update on Oral HCV Protease Inhibitor SCH 503034 Clinical Development Program for Hepatitis C
Apr 19, 06
16:33 ET	FDA Grants Fast Track Designation to Schering-Plough for its Thrombin Receptor Antagonist SCH 530348
Apr 18, 06
15:30 ET	Schering-Plough Patient Assistance Programs Offer Innovative Approach to Helping Patients Eligible for New Medicare Drug Benefit
Apr 12, 06
13:58 ET	Schering-Plough Appoints Raymond Russo Vice President, Global Cholesterol Marketing
Apr 07, 06
08:30 ET	AVELOX(R) Monotherapy as Effective as High-Dose Levofloxacin and Ceftriaxone Combination Therapy in Treating Patients With Severe Community-Acquired Pneumonia
Apr 04, 06
07:04 ET	CLARITIN(R) Partners With U.S. Men's National Soccer Team Member Landon Donovan and the American Youth Soccer Organization to Help Educate Allergy Sufferers
Mar 23, 06
08:00 ET	REMICADE(R) Is Approved in Australia for Treatment of Early Rheumatoid Arthritis and Psoriatic Arthritis
Mar 22, 06
07:01 ET	Study Shows LEVITRA(R) Treats Erectile Dysfunction Effectively in Men Taking Medications to Lower High Blood Pressure
Mar 20, 06
08:30 ET	Schering-Plough and PTC Therapeutics Announce Collaboration for Development of PTC's Preclinical Hepatitis C Compounds
Mar 17, 06
14:59 ET	Schering-Plough Announces Rodney Freeman Appointed Vice President, Global Supply Chain Management
Mar 16, 06
15:19 ET	Schering-Plough Announces Gregory J. Szpunar Appointed Group Vice President, Global Project Management, Schering-Plough Research Institute
Mar 15, 06
16:13 ET	Schering-Plough Announces Changes In Executive Finance Positions
09:05 ET	Schering-Plough Schedules Conference Call and Webcast for First Quarter 2006 Earnings
Mar 09, 06
04:01 ET	REMICADE(R) Is First Biologic Approved In European Union To Treat Ulcerative Colitis
Mar 07, 06
08:02 ET	Schering-Plough Intensifies Focus On Europe, Latin America And Asia-Pacific
Mar 06, 06
13:13 ET	Schering-Plough to Webcast CFO Robert J. Bertolini's Presentation at Lehman Brothers Ninth Annual Global Healthcare Conference
Mar 03, 06
18:15 ET	Schering-Plough Provides Update on Phase II Study of Vicriviroc
Feb 28, 06
12:41 ET	Schering-Plough Declares Quarterly Dividends on Common Shares and Mandatory Convertible Preferred Stock
Feb 27, 06
08:01 ET	Schering-Plough Appoints Tudor Panu, M.D. as General Manager, Romania
Feb 24, 06
10:54 ET	Schering-Plough Promotes Gregory Oakes to Vice President, Corporate Accounts, U.S. Managed Markets
Feb 23, 06
08:00 ET	Schering-Plough Appoints Carlos G. Dourado
Feb 22, 06
08:46 ET	Schering-Plough Reports NOXAFIL(R) (Posaconazole) NDA Granted FDA 6-Month Priority Review for Prevention of Invasive Fungal Infections
Feb 13, 06
09:40 ET	Schering-Plough Reports Garenoxacin NDA Accepted for FDA Review
Feb 10, 06
08:01 ET	Schering-Plough Presents Vicriviroc Clinical Study Results at 13th Conference on Retroviruses and Opportunistic Infections
Feb 03, 06
09:26 ET	Schering-Plough to Webcast CFO Robert J. Bertolini's Presentation at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
Feb 02, 06
07:30 ET	Health Canada Approves TEMODAL(R)(temozolomide) for Patients With Newly Diagnosed Glioblastoma Multiforme
Feb 01, 06
17:36 ET	FDA Approves CLARINEX-D(R) 12 HOUR (desloratadine 2.5mg/pseudoephedrine 120mg) Tablet Prescription Antihistamine with Decongestant for Seasonal Allergy Sufferers
Jan 30, 06
09:19 ET	Schering-Plough Reports FDA Grants Fast Track Designation to Oral HCV Protease Inhibitor SCH 503034
06:49 ET	Schering-Plough Reports Financial Results for 2005 Fourth Quarter, Full Year
02:00 ET	European Union CHMP Recommends Approval of REMICADE(R) for Treatment of Moderately to Severely Active Ulcerative Colitis
Jan 24, 06
08:32 ET	Head-To-Head Study Shows More Elderly Patients With Community-Acquired Pneumonia Recovered at Days 3 to 5 With AVELOX(R) (Moxifloxacin HCl) Compared to LEVAQUIN (Levofloxacin)
Jan 13, 06
02:30 ET	Schering-Plough Initiates PEG-INTRON(R) Maintenance Study in Patients Coinfected With Hepatitis C and HIV
Jan 09, 06
17:48 ET	Schering-Plough Appoints Michael D. Boyd Vice President, Public Affairs, International
Jan 06, 06
12:18 ET	Schering-Plough Schedules Conference Call and Webcast for Fourth Quarter 2005 Earnings
Jan 03, 06
08:40 ET	Schering-Plough Announces Completion of cGMP Work Plan, Validation Certification Program Under FDA Consent Decree
Dec 22, 05
08:30 ET	Schering-Plough Announces PEG-INTRON(R) and REBETOL(R) Approved in Japan for Expanded Use in Treating Chronic Hepatitis C
Dec 21, 05
17:26 ET	Schering-Plough to Webcast Presentation at Morgan Stanley Pharmaceutical CEOs Unplugged Conference
Dec 15, 05
11:57 ET	Schering-Plough Board of Directors Announces New Election, Governance Measures
Dec 13, 05
08:30 ET	Schering-Plough Media Alert: Data on Schering-Plough Anti-Infectives to Be Presented at ICAAC
07:45 ET	Newly Published Study Demonstrates NASONEX(R) (Mometasone Furoate Monohydrate) Effective for Nasal Polyps With Once- or Twice-Daily Dose
Dec 12, 05
08:31 ET	New Study Shows NOXAFIL(R) (Posaconazole) Oral Suspension Significantly Reduced Invasive Fungal Infections, Aspergillosis, Compared to Standard Azole Antifungals in High-Risk Chemotherapy Patients
Dec 07, 05
16:47 ET	Schering-Plough Reports West Virginia Jury Finds in Favor of Company in Reimbursement Case
Dec 06, 05
12:34 ET	Schering-Plough Declares Quarterly Dividends on Common Shares and Mandatory Convertible Preferred Stock
Dec 05, 05
16:34 ET	Schering-Plough Elects C. Robert Kidder to Board of Directors
Nov 30, 05
08:30 ET	FDA Approves New Indication for AVELOX(R) (moxifloxacin HCl) for Treatment of Complicated Intra-Abdominal Infections (cIAI)
Nov 16, 05
14:24 ET	Schering-Plough to Webcast Presentation at Credit Suisse First Boston Annual Health Care Conference
08:58 ET	Schering-Plough and ONCOMETHYLOME Sciences (OMS) Announce License and Collaboration Agreement For Use of OMS Pharmacogenomic Technology
Nov 15, 05
09:03 ET	HOMEAGAIN(R) Announces New Scanners Will Read All 125 kHz Microchips and Detect 134kHz Chips
Nov 14, 05
08:00 ET	Schering-Plough's Oral HCV Protease Inhibitor Demonstrates Potent Antiviral Activity as Monotherapy and in Combination With PEG-INTRON(R) in Phase I Studies
Nov 12, 05
05:07 ET	PEG-INTRON(R) and REBETOL(R) Combination Therapy Demonstrates Consistently High Response Rates Across Patient Weight Groups in 'Real-Life' Treatment Setting
Nov 10, 05
12:02 ET	Schering-Plough Promotes Jeffrey Berkowitz To Group Vice President, U.S. Managed Markets
Nov 09, 05
08:30 ET	Schering-Plough Appoints New General Manager for the Netherlands
Nov 08, 05
11:34 ET	Data Show Morning Is the Most Difficult Time for Allergic Rhinitis Sufferers
11:32 ET	Data Show Nasal Congestion is Most Bothersome Symptom of Allergic Rhinitis
Nov 07, 05
08:05 ET	Data on Schering-Plough's Oral HCV Protease Inhibitor to be Presented for First Time at American Association for the Study of Liver Diseases (AASLD) Meeting
Nov 01, 05
14:54 ET	Schering-Plough Highlights R&D Pipeline and Product Portfolio at Analysts and Portfolio Managers Meeting
08:03 ET	Schering-Plough Submits New Drug Application In Japan for TEMODAL(R) In Treating Malignant Glioma
Oct 31, 05
03:15 ET	TEMODAL (R) After Surgery Significantly Improves Survival in Patients With Newly Diagnosed Glioblastoma Multiforme
Oct 27, 05
20:14 ET	Schering-Plough Discontinues Phase II Study of Vicriviroc in Treatment-Naive HIV Patients, Continues Phase II Study in Treatment-Experienced HIV Patients
02:00 ET	NOXAFIL(R) (Posaconazole) Oral Suspension Approved in European Union for Treatment of Invasive Fungal Infections
Oct 25, 05
03:01 ET	New Study Shows NOXAFIL(R) (Posaconazole) Oral Suspension Significantly Reduced Aspergillosis, Invasive Fungal Infections, Compared to Fluconazole, in Allogeneic Hematopoietic Stem Cell Transplant Recipients With Graft-Versus-Host Disease
Oct 24, 05
06:56 ET	Schering-Plough Reports 2005 Third Quarter Financial Results
Oct 21, 05
08:57 ET	Schering-Plough to Webcast 'R&D and Product Review' Meeting
Oct 19, 05
08:14 ET	New Study Will Determine If Comprehensive Anti-Platelet Therapy Can Prevent Heart Damage
Oct 12, 05
07:55 ET	Survey Finds Nearly Half of Persistent Asthma Sufferers Experience Their Worst Symptoms in The Evening and Nighttime
Oct 06, 05
06:01 ET	REMICADE(R) Receives Approval in European Union for Treatment of Moderate to Severe Plaque Psoriasis
Oct 05, 05
09:34 ET	Shorter Course of PEG-INTRON(R) and REBETOL(R) Combination Therapy Approved in European Union for Certain Hepatitis C Patients With Genotype 1 and Low Viral Load
Sep 28, 05
10:01 ET	Schering-Plough Announces Appointments in Global Pharmaceutical Business
Sep 21, 05
12:02 ET	Schering-Plough Appoints Leigh Ann Nicholson-Errico Vice President, Human Resources, Global Pharmaceutical Business - U.S.
Sep 20, 05
12:04 ET	Schering-Plough Declares Quarterly Dividends on Common Shares and Mandatory Convertible Preferred Stock
Sep 14, 05
18:01 ET	Schering-Plough Schedules Conference Call and Webcast for Third Quarter 2005 Earnings
Sep 12, 05
09:56 ET	Schering-Plough To Webcast Presentation at Bear, Stearns 18th Annual Healthcare Conference
09:03 ET	Schering-Plough Named Among Top 10 In The Nation For Working Mothers
Sep 07, 05
08:30 ET	Schering-Plough Appoints New General Managers For Poland and The Philippines
Sep 06, 05
12:28 ET	Research Shows Patients With Allergic Rhinitis Prefer NASONEX(R) (Mometasone Furoate Monohydrate) To Flonase(R) for Scent and Taste
Sep 01, 05
16:32 ET	Schering-Plough to Provide Financial, Product Donations in Support of Hurricane Katrina Relief Effort
Aug 26, 05
08:40 ET	New Grape-Flavored CHILDREN'S CLARITIN(R) Syrup Delivers Powerful Allergy Relief With No Bitter Aftertaste
Aug 16, 05
08:09 ET	Schering-Plough Exercises Rights to Centocor's CNTO 148 Anti-TNF Agent
Aug 04, 05
20:00 ET	Schering-Plough and Sankyo Enter License Agreement for Olmesartan in Select Latin American Territories
Aug 02, 05
11:50 ET	Schering-Plough Appoints Jacqueline Crew, Ph.D., Vice President, Pharmaceutical Sciences Quality
Aug 01, 05
12:25 ET	Schering-Plough Appoints Paul Medeiros Vice President, Global Licensing
Jul 29, 05
09:21 ET	European Union's CHMP Adopts Positive Opinion For Shorter Course of PEGINTRON(R) and REBETOL(R) Combination Therapy For Certain Hepatitis C Patients With Genotype 1 and Low Viral Load
Jul 28, 05
13:07 ET	European Union's CHMP Adopts Positive Opinion for NOXAFIL(R) (posaconazole) Oral Suspension for Treatment of Invasive Fungal Infections
Jul 22, 05
16:01 ET	Schering-Plough to Acquire From Millennium Exclusive U.S. Marketing Rights for INTEGRILIN(R) (eptifibatide) Injection
13:11 ET	Schering-Plough Appoints John O'Mullane Group Vice President, Research and Development, Consumer Health Care
Jul 21, 05
06:53 ET	Schering-Plough Reports Financial Results for 2005 Second Quarter
Jul 15, 05
08:30 ET	FDA Approves Re-Formulated CLARINEX(R) (desloratadine) REDITABS(R) Tablets - Orally Disintegrating Prescription Antihistamine
Jul 06, 05
08:31 ET	Schering-Plough Expands Its Presence in Asia Pacific; Commercial Operations Opened in Korea and Pakistan
Jun 30, 05
08:31 ET	Schering-Plough Announces FDA Approval of AVELOX(R) (moxifloxacin HCl) for Treatment of Complicated Skin and Skin Structure Infections
Jun 29, 05
06:06 ET	NASONEX(R) (mometasone furoate monohydrate) Effective for Nasal Polyps with Once-Daily Dose
Jun 28, 05
16:03 ET	Schering-Plough Elects Thomas J. Colligan to Board of Directors
14:26 ET	Schering-Plough Declares Quarterly Dividends on Common Shares and Mandatory Convertible Preferred Stock
Jun 23, 05
13:22 ET	Consumer Poll: Food Safety Confidence Will Improve With Mandatory National Animal Identification System
Jun 22, 05
17:05 ET	Study Shows 12 Weeks of Peginterferon Alfa-2b and Ribavirin Combination Therapy as Effective as 24 Weeks in Certain Hepatitis C Patients With Genotype 2 or 3 Virus
Jun 17, 05
15:50 ET	Schering-Plough Appoints Miguel Ribas General Manager, San Juan, Puerto Rico
Jun 10, 05
16:00 ET	Schering-Plough to Webcast Presentation at Goldman Sachs Global Healthcare Conference
06:00 ET	TEMODAL(R) Approved in European Union For Treatment of Newly Diagnosed Glioblastoma Multiforme
Jun 09, 05
12:02 ET	Schering-Plough Schedules Conference Call and Webcast For Second Quarter 2005 Earnings
May 31, 05
10:17 ET	Schering-Plough to Webcast CEO Fred Hassan's Presentation at Sanford Bernstein Strategic Decisions Conference
May 26, 05
16:30 ET	Schering-Plough Appoints Sumant Ramachandra, M.D., Ph.D., Vice President, Global Project Management, Schering-Plough Research Institute
16:26 ET	Schering-Plough Appoints Michael Perelman, M.D., Vice President, Global Project Management, Schering-Plough Research Institute
May 12, 05
10:15 ET	Data on PEG-INTRON(R) and REBETOL(R) Combination Therapy in Diverse Patient Populations to Be Presented at 2005 Digestive Disease Week (DDW) Meeting
May 06, 05
08:40 ET	Schering-Plough Appoints Jim Joyce as Country Manager, Ireland
May 03, 05
12:22 ET	Schering-Plough Announces Integration of West Coast Research Facilities
09:23 ET	Schering-Plough to Webcast CFO Robert J. Bertolini's Presentation at Deutsche Bank 30th Annual Health Care Conference
Apr 29, 05
09:32 ET	Schering-Plough Appoints Theo Nieuwenhuis Vice President, REMICADE Marketing
Apr 26, 05
16:12 ET	Schering-Plough Chairman/CEO Fred Hassan Reviews Progress in Action Agenda at Annual Shareholders Meeting
Apr 25, 05
19:14 ET	Schering-Plough Declares Quarterly Dividends on Common Shares and Mandatory Convertible Preferred Stock
08:54 ET	Schering-Plough Appoints John Howell as General Manager, Brinny, Ireland
Apr 22, 05
09:08 ET	European Union's CHMP Recommends Approval of TEMODAL(R) (Temozolomide) for the Most Common and Aggressive Form of Brain Cancer
Apr 21, 05
17:54 ET	Schering-Plough Reports Financial Results for 2005 First Quarter
Apr 20, 05
09:22 ET	Schering-Plough Schedules Webcast for Annual Meeting of Shareholders
Apr 18, 05
04:00 ET	Clinical Benefits of Retreatment With PegIntron and Rebetol Combination Therapy Demonstrated in Difficult-to-Treat Hepatitis C Patients
Apr 14, 05
11:32 ET	Schering-Plough Appoints Urban Widen as General Manager, Sweden
Apr 05, 05
14:59 ET	Head of Schering-Plough Research Institute Named to New Jersey High-Tech Hall of Fame
Mar 31, 05
08:39 ET	FDA Approves ASMANEX(R) (mometasone furoate) for Once Daily Management of Asthma
Mar 28, 05
08:50 ET	Spring Allergies May Limit Attention Span and Impair Memory as Well as Cause Sniffles and Sneezes
Mar 22, 05
17:24 ET	CLARITIN(R) OTC Brand Sales Surpass $1 Billion Mark in U.S.
10:20 ET	Schering-Plough Appoints Susan G. Arbuck, M.D., Vice President, Global Clinical Development, Schering-Plough Research Institute
Mar 18, 05
14:20 ET	Schering-Plough Schedules Conference Call and Webcast for First Quarter 2005 Earnings
Mar 16, 05
11:31 ET	FDA Approves TEMODAR(R) (temozolomide) as Treatment for Patients With Newly Diagnosed Glioblastoma Multiforme
Mar 09, 05
17:02 ET	Breakthrough in Medical Research: New Chemotherapy Gives Hope to Brain Tumour Patients. A Clear Improvement in Survival Demonstrated for Glioblastoma
17:01 ET	Schering-Plough Reports Federal Appeals Court Rules in Favor of Company on K-DUR Antitrust Matter
Mar 04, 05
16:44 ET	Schering-Plough Appoints Elpidio Villarreal Vice President & Associate General Counsel, Litigation & Conflict Management
08:11 ET	FDA Approves CLARINEX-D(R) 24 HOUR Prescription-Strength Once-Daily Nondrowsy Antihistamine with a Decongestant
Mar 03, 05
13:30 ET	Schering-Plough Appoints James F. McLeod, M.D., Vice President, Global Clinical Development, Early Research & Experimental Medicine
Mar 02, 05
17:13 ET	Schering-Plough Appoints Christopher Kelly Vice President, Global Information Technology, Global Supply Chain/Global Quality Operations
Feb 28, 05
08:31 ET	Schering-Plough Appoints Guy Fekete General Manager, Animal Health, France
Feb 18, 05
10:55 ET	Schering-Plough Completes Acquisition of Most NeoGenesis' Assets
Feb 14, 05
13:10 ET	Schering-Plough Appoints Winston K.C. Lam Vice President And Associate General Counsel
Feb 11, 05
08:30 ET	Schering-Plough Appoints Dr. Armando Trujillo, Vice President and General Manager for Mexico Operations
Feb 10, 05
10:51 ET	Schering-Plough Appoints Charles Schultes Group Vice President, Finance, Global Pharmaceutical Business
Feb 09, 05
16:39 ET	Schering-Plough Mourns Death of Former Executive Steven C. Chellevold
Feb 08, 05
08:32 ET	NJPAC Adds Four Senior Executives to Board of Directors
Feb 07, 05
10:02 ET	Schering-Plough to Webcast CFO Robert J. Bertolini's Presentation at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
Feb 03, 05
15:08 ET	Head of Schering-Plough Global Communications Named 2004 Communicator of the Year
Jan 25, 05
13:43 ET	Schering-Plough Declares Quarterly Dividends On Common Shares and Mandatory Convertible Preferred Stock
06